46 - 53
A Comprehensive Review on Cancer Associated Deep Vein Thrombosis
Authors: Srinivas Velishetty1, Putcha Udaykumar2, Pinninti Santosh Sushma 2, Malladi Ramakrishna*1
Number of views: 446
Cancer-associated thrombosis accounts for almost one-fifth of all cases of venous thromboembolism (VTE) and is a leading cause of death, morbidity, delays in care, and increased costs. Our understanding of risk factors for cancer-associated thrombosis has expanded in recent years, and investigators have begun to use biomarkers and clinical prediction models to identify those cancer patients at greatest risk for VTE. A thrombus either arises spontaneously or is caused by clinical conditions including surgery, trauma, or prolonged bed rest. In these instances, prophylaxis with low-dose anticoagulation is effective. Diagnosis of deep vein thrombosis relies on imaging techniques such as ultrasonography or venography. Only about 25% of symptomatic patients have a thrombus. Risk factors, cancer associated risk factors, pathophysiology and diagnosis is discussed here under.